VeriStrat (R) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib

J.L. Kuiper, J.S.W. Lind, H.J.M. Groen, J. Roder, J. Grigorieva, H. Roder, A.M.C. Dingemans, E.F. Smit

Research output: Contribution to journalArticleAcademicpeer-review

71 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)1820-1825
JournalBritish Journal of Cancer
Issue number11
Publication statusPublished - 2012

Cite this